Eupraxia Pharmaceuticals(EPRX)
$7.81-0.25 (-3.10%)
EPRX
Eupraxia Pharmaceuticals earnings date
$7.81
At close:-0.25 (-3.10%)
Eupraxia Pharmaceuticals (EPRX) Q2 2021 Earnings Report
48 Followers
EPRX Q2 2021 EPS Results
- Actual EPS
- -$0.29
- Consensus EPS
- -$0.42
- Beat/Miss
- Beat by +$0.13
- One Year Ago EPS
- ―
EPRX Q2 2021 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/13/2021
- Time
- After Close
- Conference Call
- Friday, August 13, 2021
EPRX Upcoming Earnings
Eupraxia Pharmaceuticals's next earnings date is estimated for March 30, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
EPRX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 30, 2027 | 2026 (Q4) | -0.27- | -0.32 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.26-0.23 | -0.19 | -18.95% (-0.04) | |
| Aug 11, 2026 | 2026 (Q2) | -0.22-0.22 | -0.24 | 8.68% (+0.02) | |
| May 12, 2026 | 2026 (Q1) | -0.19-0.23 | -0.19 | -21.05% (-0.04) | |
| Mar 13, 2026 | 2025 (Q4) | -0.15-0.32 | -0.21 | -52.38% (-0.11) | |
| Nov 04, 2025 | 2025 (Q3) | -0.18-0.19 | -0.12 | -57.02% (-0.07) | |
| Aug 12, 2025 | 2025 (Q2) | -0.19-0.24 | -0.12 | -95.16% (-0.12) | |
| May 06, 2025 | 2025 (Q1) | -0.17-0.19 | -0.21 | 9.52% (+0.02) | |
| Mar 20, 2025 | 2024 (Q4) | -0.15-0.21 | -0.27 | 22.22% (+0.06) | |
| Nov 07, 2024 | 2024 (Q3) | -0.13-0.12 | -0.11 | -8.04% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
